Uterine sarcomas comprise a group of rare tumors with differing tumor biology, natural
history and response to treatment. Diagnosis is often made following surgery for presumed …

Uterine sarcomas are very infrequent and heterogeneous entities. Due to its rarity,
pathological diagnosis, surgical management, and systemic treatment are challenging …

Adenosarcomas are rare malignancies of the female genital tract, accounting for
approximately 5% of uterine sarcomas. Occasionally, adenosarcoma occurs in the ovaries …

Background Uterine sarcomas are very rare tumours with different histotypes, molecular
features and clinical outcomes; therefore, it is difficult to carry out prospective clinical trials …

Soft tissue sarcomas (STS) are rare tumours arising in mesenchymal tissues and can occur
almost anywhere in the body. Their rarity, and the heterogeneity of subtype and location …

Uterine sarcomas reflect the diversity of sarcoma as a whole. The most common histologies
include leiomyosarcoma, high-and low-grade endometrial stromal sarcoma, and …

Trabectedin, a tetrahydroisoquinoline alkaloid, is the first marine antineoplastic agent
approved with special anticancer mechanisms involving DNA binding, DNA repair …

Objective Uterine adenosarcoma (UAS) is a rare gynecologic malignancy and the
significance of lymph node metastasis on survival has not been well studied. Methods A …

Uterine adenosarcoma is a rare malignancy. It is defined as a biphasic tumor composed of
both sarcomatous stroma and benign epithelium. While the sarcomatous component usually …

Gynecological sarcomas represent 3% to 4% of all gynecological malignancies and 13% of
all sarcomas. The uterus is the most frequent primary site (83%); less frequently sarcomas …